Unilever Acquires Grüns and Dr. Squatch for $1.2 Billion

British consumer goods giant Unilever has strategically transformed its business over the past decade, divesting its food operations to focus on personal care, beauty, and wellness sectors. This pivot includes significant acquisitions, such as the earlier purchase of the gummy supplement company Grüns for a reported $1.2 billion. Unilever's divestitures have been substantial, including the sale of its margarine and spreads business to KKR in 2019 and the spin-off of Magnum Ice Cream in 2025. Furthermore, the company announced plans to combine its remaining food portfolio, which features brands like Hellmann's and Knorr, with spice maker McCormick in a transaction valuing Unilever at $44.8 billion, with this deal anticipated to finalize next year. This strategic realignment aims to create an enterprise that is a "pure play" in the high-growth personal care, beauty, and wellness markets.

Unilever U.S. is projected to become a focused $9.4 billion business operating within these attractive segments, according to Herrish Patel, president of Unilever USA and CEO of Unilever Personal Care North America. Patel highlighted the company's "beautiful stable of brands," which includes both established legacy names and newer entrants. The personal care brand Dove, launched in 1957, exemplifies Unilever's growth strategy through innovation, creative packaging, and "premiumization." Dove has successfully attracted new consumer demographics through unconventional collaborations, such as a partnership with the Netflix series Bridgerton and the cookie chain Crumbl. The brand has also subtly moved upmarket by incorporating serums, which are highly concentrated formulations, into select hair and skincare products, demonstrating a commitment to enhancing product offerings without straying from its core identity.

The acquisition of Grüns, a company specializing in gummy supplements, signifies Unilever's intent to bolster its presence in the rapidly expanding wellness market. While the specific details of the Dr. Squatch acquisition are not provided in this context, its mention alongside Grüns suggests a similar strategic interest in direct-to-consumer or niche personal care brands that align with Unilever's new focus. This move towards acquiring innovative and fast-growing brands in the personal care and wellness space is a key component of Unilever's broader strategy to adapt to evolving consumer preferences and market trends. The company's transformation underscores a deliberate effort to shed slower-growing or less strategic assets while investing in areas with higher potential for growth and profitability. The emphasis on premiumization and innovative product development, as seen with Dove, further illustrates Unilever's commitment to enhancing brand value and consumer appeal in its target markets. The company's leadership, including Patel, has articulated a clear vision for this future, emphasizing the strength and growth potential of its curated brand portfolio.